Posts by: Joana Fernandes, PhD

Joana Fernandes, PhD

Joana brings more than 8 years of academic research and experience as well as Scientific writing and editing to her role as a Science and Research writer. She also served as a Postdoctoral Researcher at the Center for Neuroscience and Cell Biology in Coimbra, Portugal, where she also received her PhD in Health Science and Technologies, with a specialty in Molecular and Cellular Biology.

March 27, 2017March 27, 2017

Researchers Map 3D Structure of CFTR, the Protein Involved in Cystic Fibrosis

cystic fibrosis, News

Rockefeller University researchers have mapped the three-dimensional structure of the protein involved in cystic fibrosis (CF). The mapping is important because knowing more about the CFTR protein will provide scientists ... Read more

March 23, 2017March 23, 2017

Sound Pharmaceuticals Gets $1.6 Million to Test SPI-1005 as CF Hearing Loss Therapy

cystic fibrosis, News

Sound Pharmaceuticals has received a $1.6 million Cystic Fibrosis Foundation Therapeutics (CFFT) grant to test a therapy it has developed to improve hearing loss in cystic fibrosis (CF) patients being treated with tobramycin. Tobramycin ... Read more

March 15, 2017March 15, 2017

Using Virus May Be Way to Fight Resistant Bacterial Lung Infections, Study Reports

cystic fibrosis, News

Using a virus may be a reliable way to treat antibiotic-resistant bacterial infections in cystic fibrosis (CF) patients’ lungs, according to a study. The approach is called phage therapy. ... Read more

March 6, 2017March 6, 2017

Ataluren Fails to Pass Muster as Treatment for Severe Form of Cystic Fibrosis

cystic fibrosis, News

PTC Therapeutics’ ataluren has failed to significantly improve respiratory function in nonsense mutation cystic fibrosis (nmCF), a severe form of the disease, according to results of a Phase 3 clinical ... Read more

February 27, 2017February 27, 2017

Resunab Shows Potential in Treating Lung Inflammation in Preclinical Study

cystic fibrosis, News

The investigative oral treatment Resunab (JBT-101) shows promise in easing inflammation mediated by immune cells in the lungs of cystic fibrosis (CF) patients, according to results of a preclinical study. Results from a Phase 2 study of ... Read more

February 14, 2017February 14, 2017

Pre-flight Check Can Predict CF Patients’ Need for Supplemental Oxygen on Plane, Study Reports

cystic fibrosis, News

Evaluating patients with cystic fibrosis (CF) before they board a flight may help predict whether they will need supplemental oxygen while in the air to prevent a severe decrease ... Read more

February 3, 2017February 3, 2017

New Guidelines for CF Diagnosis Draw on New Understanding of Disease and Its Mutations

cystic fibrosis, News

Guidelines for diagnosing cystic fibrosis (CF) were recently updated to give doctors firmer direction in determining signs of this disease, especially in those not diagnosed as newborns, and in being able to ... Read more

February 2, 2017February 2, 2017

First-of-its-kind Study Explores if Stem Cells Might Lessen Inflammation in CF Patients

cystic fibrosis, News

An Ohio cystic fibrosis (CF) patient was given an infusion of adult stem cells in a pioneering study that researchers hope will lead to therapies that reduce inflammation and infections linked ... Read more

January 26, 2017January 26, 2017

CFF Leader Talks About ‘Open Letter’ to President and Concerns with Healthcare Reform

News

The Cystic Fibrosis Foundation (CFF) joined 72 other organizations, each advocating for patients with chronic, rare and life-threatening diseases, in an open letter to President Donald Trump and leaders in Congress. The letter asks ... Read more

January 20, 2017January 20, 2017

Work on Pulmatrix’s PUR1900 for Fungal Infections in CF Patients Bolstered by FDA

cystic fibrosis, News

The U.S. Food and Drug Administration (FDA) has designated PUR1900 a Qualified Infectious Disease Product (QIDP) as a potential treatment of fungal infections in the lungs of patients with cystic fibrosis(CF), its ... Read more